Connect with us

Business

Putin announced that Russia approved a COVID-19 vaccine — and gave it to his daughter — despite serious concerns over its safety

Russian President Vladimir Putin said on Tuesday that Russia had approved a COVID-19 vaccine, the world’s first. ‘I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks,’ Putin said on Tuesday. The move has raised concerns because it has not yet undergone Phase III trials,…

Published

on

Putin announced that Russia approved a COVID-19 vaccine — and gave it to his daughter — despite serious concerns over its safety

Russian President Vladimir Putin said on Tuesday that Russia had approved a COVID-19 vaccine, the world’s first.
‘I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks,’ Putin said on Tuesday.
The move has raised concerns because it has not yet undergone Phase III trials, which are considered essential to guarantee the safety of a vaccine.
Visit Business Insider’s homepage for more stories.

Russian President Vladimir Putin says his government has approved the world’s first coronavirus vaccine, and even given his daughter a shot of the treatment, despite concerns that the product has not been properly tested.
“I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks,” Putin said on Tuesday, according to Reuters.
He said one of his two daughters had been given the treatment and was feeling well, according to the Associated Press, adding that he hoped the vaccine would begin mass production soon.
Russia has rolled out a vaccine at an extremely fast pace. Some officials have characterized the process as a race with other nations, particularly the US.
But scientists outside Russia have raised significant concerns about the so-called Gamaleya vaccine, named after the Gamaleya Institute in Moscow where it is being developed.
The concerns stem from the fact that the vaccine has not undergone Phase III trials, which are considered essential to guarantee the safety of a vaccine.
There were widespread reports last month that scientists at the Gamaleya Institute had injected themselves with the prototype to speed up the development, and rushed through other tests.
Phase III trials, which usually involve thousands of participants, will instead begin after the vaccine has received regulatory approval, Reuters reported.
Russian government sources told Reuters last month that health workers would be offered the vaccine on a voluntary basis after it had received regulatory approval.Join the conversation about this story » NOW WATCH: Inside London during COVID-19 lockdown
Read More